What is Microbot Medical's deferred issuance costs?

Microbot Medical (MBOT) reported deferred issuance costs of $30K in Q1 2025.

What does deferred issuance costs mean?

This metric tracks costs related to the issuance of securities that are capitalized and amortized over the life of the instrument rather than expensed immediately. It represents the upfront investment required to access capital markets, such as legal, accounting, and underwriting fees. Monitoring these costs helps evaluate the efficiency of the company's capital raising processes.

Microbot Medical MBOT Deferred Issuance Costs

Deferred Issuance Costs at other companies

Bain Capital Specialty FinanceBCSF

$3.29M-24.2%

NextNRG, Inc. Common StockNXXT

$18.09K-98.8%

Oaktree Specialty LendingOCSL

$43K-73.3%

Patriot National BancorpPNBK

$0+100%

Rumble, Inc.RUM

$220K—

Garrett Motion Inc.GTX

$1.75M-81.1%

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept MBOT:DeferredIssuanceCosts.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's deferred issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's deferred issuance costs?: Microbot Medical (MBOT) reported deferred issuance costs of $30K in Q1 2025.
What does deferred issuance costs mean?: This metric tracks costs related to the issuance of securities that are capitalized and amortized over the life of the instrument rather than expensed immediately. It represents the upfront investment required to access capital markets, such as legal, accounting, and underwriting fees. Monitoring these costs helps evaluate the efficiency of the company's capital raising processes.